| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MOLMED.2010.02.005 |
| P8608 | Fatcat ID | release_7cfyktzdfrg5nnreu7ucr25snq |
| P932 | PMC publication ID | 2881950 |
| P698 | PubMed publication ID | 20335067 |
| P5875 | ResearchGate publication ID | 42541261 |
| P50 | author | James A Ankrum | Q62577277 |
| P2093 | author name string | Jeffrey M Karp | |
| James Ankrum | |||
| P2860 | cites work | Regenerating the heart | Q22251075 |
| A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44 | Q24297519 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views | Q28251015 | ||
| Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone | Q28264546 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Mesenchymal stem cells reside in virtually all post-natal organs and tissues | Q29617740 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
| Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 | ||
| Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction | Q30477220 | ||
| In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment | Q30484167 | ||
| Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche | Q30493093 | ||
| Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics | Q30541132 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Why are MSCs therapeutic? New data: new insight. | Q33386080 | ||
| Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopy | Q33571085 | ||
| Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms | Q33713663 | ||
| Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging | Q34162598 | ||
| Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging | Q34164696 | ||
| Fibroblast precursors in normal and irradiated mouse hematopoietic organs | Q34474362 | ||
| TSG-6: a pluripotent inflammatory mediator? | Q34527768 | ||
| Mesenchymal stem cells and their potential as cardiac therapeutics | Q35830869 | ||
| Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury | Q35841729 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells | Q36709408 | ||
| Immunomodulatory properties of mesenchymal stromal cells | Q36896799 | ||
| Mesenchymal stem cells: revisiting history, concepts, and assays. | Q37036368 | ||
| The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice | Q37071096 | ||
| Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells | Q37134013 | ||
| Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. | Q37310724 | ||
| Mesenchymal stem cell homing: the devil is in the details | Q37407769 | ||
| Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy | Q37420332 | ||
| Optimizing mesenchymal stem cell-based therapeutics. | Q37604019 | ||
| Labeling of mesenchymal stem cells by bioconjugated quantum dots | Q39978227 | ||
| Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis | Q41940674 | ||
| Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment | Q42853310 | ||
| The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 | ||
| Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. | Q44538164 | ||
| Stem cell transplantation: the lung barrier. | Q46028067 | ||
| In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction | Q50765152 | ||
| Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury | Q51085218 | ||
| Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. | Q52008649 | ||
| Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. | Q53606669 | ||
| Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment | Q73168627 | ||
| Bone marrow cell trafficking following intravenous administration | Q73293668 | ||
| Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
| Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture | Q78800357 | ||
| Distribution of circulation-derived endothelial progenitors following systemic delivery | Q79963887 | ||
| Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells | Q80077858 | ||
| P433 | issue | 5 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 203-209 | |
| P577 | publication date | 2010-03-23 | |
| P1433 | published in | Trends in Molecular Medicine | Q15265842 |
| P1476 | title | Mesenchymal stem cell therapy: Two steps forward, one step back | |
| P478 | volume | 16 |
| Q92313333 | A Human Umbilical Cord Mesenchymal Stem Cell-Conditioned Medium/Chitosan/Collagen/β-Glycerophosphate Thermosensitive Hydrogel Promotes Burn Injury Healing in Mice |
| Q27332197 | A causal relation between bioluminescence and oxygen to quantify the cell niche |
| Q37457516 | A cell rolling cytometer reveals the correlation between mesenchymal stem cell dynamic adhesion and differentiation state. |
| Q33917928 | A novel albumin-based tissue scaffold for autogenic tissue engineering applications |
| Q39298233 | A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion |
| Q36776738 | A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer |
| Q27321219 | A small-molecule screen for enhanced homing of systemically infused cells |
| Q38091722 | Achieving operational tolerance in transplantation: how can lessons from the clinic inform research directions? |
| Q33660533 | Activated omentum slows progression of CKD. |
| Q97536490 | Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice |
| Q50531560 | Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production |
| Q34165095 | Adult human adipose tissue contains several types of multipotent cells |
| Q46109351 | Adult multipotent stromal cell cryopreservation: Pluses and pitfalls |
| Q41244672 | Adult neural stem cells: Long-term self-renewal, replenishment by the immune system, or both? |
| Q94018218 | Advances in Single-cell Tracking of Mesenchymal Stem Cells (MSCs) During Musculoskeletal Regeneration |
| Q91811850 | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications |
| Q40057019 | Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Expanded In Vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial |
| Q38064659 | Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? |
| Q38678597 | Australasian College of Sports Physicians-position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine |
| Q38453650 | Avoiding immunological rejection in regenerative medicine. |
| Q36357726 | Benefits of hypoxic culture on bone marrow multipotent stromal cells. |
| Q46280532 | Biodegradation, biocompatibility, and osteoconduction evaluation of collagen-nanohydroxyapatite cryogels for bone tissue regeneration |
| Q38837608 | Biodistribution and Clearance of Human Mesenchymal Stem Cells by Quantitative Three-Dimensional Cryo-Imaging After Intravenous Infusion in a Rat Lung Injury Model |
| Q57470597 | Bioengineering human vascular networks: trends and directions in endothelial and perivascular cell sources |
| Q38213555 | Bioengineering tools to elucidate and control the fate of transplanted stem cells. |
| Q99557875 | Biological properties of bone marrow stem cells and adipose-derived stem cells derived from T2DM rats: a comparative study |
| Q64089213 | Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells |
| Q46437473 | Blood-derived stem cells (BDSCs) plasticity: in vitro hepatic differentiation |
| Q26740083 | Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies |
| Q90183606 | Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN |
| Q36490828 | Bone regeneration by transplantation of human mesenchymal stromal cells in a rabbit mandibular distraction osteogenesis model |
| Q39027200 | CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect |
| Q50650777 | CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact Hypersensitivity |
| Q51285452 | Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. |
| Q41160345 | Cell number and chondrogenesis in human mesenchymal stem cell aggregates is affected by the sulfation level of heparin used as a cell coating |
| Q33970350 | Cell therapy with human MSCs isolated from the umbilical cord Wharton jelly associated to a PVA membrane in the treatment of chronic skin wounds. |
| Q42605124 | Cell therapy--showing cells the way home |
| Q38265206 | Cell-based therapy approaches: the hope for incurable diseases |
| Q34275442 | Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs |
| Q35185609 | Cell-surface sensors for real-time probing of cellular environments |
| Q38023800 | Cell-surface sensors: lighting the cellular environment |
| Q35739401 | Challenges in the translation and commercialization of cell therapies |
| Q38954041 | Characterization and Comparison of Canine Multipotent Stromal Cells Derived from Liver and Bone Marrow |
| Q41836505 | Characterization of a multilayer heparin coating for biomolecule presentation to human mesenchymal stem cell spheroids |
| Q39837580 | Chemically primed bone-marrow derived mesenchymal stem cells show enhanced expression of chemokine receptors contributed to their migration capability |
| Q49229566 | Chitosan composite scaffold combined with bone marrow-derived mesenchymal stem cells for bone regeneration: in vitro and in vivo evaluation |
| Q39154189 | Concise Review: Innate and Adaptive Immune Recognition of Allogeneic and Xenogeneic Cell Transplants in the Central Nervous System. |
| Q58804653 | Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise |
| Q38314852 | Concise Review: Mesenchymal Stem Cells Ameliorate Tissue Injury via Secretion of Tumor Necrosis Factor-α Stimulated Protein/Gene 6. |
| Q37200221 | Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. |
| Q36089997 | Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems |
| Q38152408 | Concise review: the immune status of mesenchymal stem cells and its relevance for therapeutic application |
| Q35752045 | Conditions to improve expansion of human mesenchymal stem cells based on rat samples |
| Q42375981 | Controlled delivery and minimally invasive imaging of stem cells in the lung |
| Q36925541 | Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy |
| Q50224283 | Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy? |
| Q39265654 | Decidua mesenchymal stem cells migrated toward mammary tumors in vitro and in vivo affecting tumor growth and tumor development |
| Q39614101 | Defining Molecular Phenotypes of Mesenchymal and hematopoietic Stem Cells derived from Peripheral blood of Acute Lymphocytic Leukemia patients for regenerative stem cell therapy |
| Q34432396 | Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice |
| Q89848756 | Dental Stem Cell-Derived Secretome/Conditioned Medium: The Future for Regenerative Therapeutic Applications |
| Q35295088 | Dental follicle cells rescue the regenerative capacity of periodontal ligament stem cells in an inflammatory microenvironment |
| Q39407951 | Direct head-to-head comparison of cationic liposome-mediated gene delivery to mesenchymal stem/stromal cells of different human sources: a comprehensive study |
| Q37472831 | Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells? |
| Q46332910 | Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model? |
| Q35240062 | Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? |
| Q55065461 | Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells. |
| Q51639747 | Early Passage Dependence of Mesenchymal Stem Cell Mechanics Influences Cellular Invasion and Migration. |
| Q33805883 | Effect of CXCR3/HO-1 genes modified bone marrow mesenchymal stem cells on small bowel transplant rejection |
| Q58596811 | Effectiveness of a single intra-articular bone marrow aspirate concentrate (BMAC) injection in patients with grade 3 and 4 knee osteoarthritis |
| Q50276818 | Effects of diagnostic ultrasound-targeted microbubble destruction on the homing ability of bone marrow stromal cells to the kidney parenchyma |
| Q93155206 | Efficacy of 3D Culture Priming is Maintained in Human Mesenchymal Stem Cells after Extensive Expansion of the Cells |
| Q89537050 | Efficient Labeling Of Mesenchymal Stem Cells For High Sensitivity Long-Term MRI Monitoring In Live Mice Brains |
| Q36709351 | Embryonic Stem Cells-loaded Gelatin Microcryogels Slow Progression of Chronic Kidney Disease |
| Q58548409 | Emerging Interventions for the Elderly - The Promise of Regenerative Medicine |
| Q35623682 | Engineered cell homing |
| Q37718020 | Establishing criteria for human mesenchymal stem cell potency |
| Q42103079 | Evaluation of insulin medium or chondrogenic medium on proliferation and chondrogenesis of ATDC5 cells |
| Q37150333 | Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. |
| Q53554451 | Ex Vivo Induced Regulatory Human/Murine Mesenchymal Stem Cells as Immune Modulators. |
| Q38014437 | Ex vivo expansion of human mesenchymal stem cells in defined serum-free media |
| Q36082553 | Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay. |
| Q38180964 | Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages |
| Q46836604 | Factors enhancing the migration and the homing of mesenchymal stem cells in experimentally induced cardiotoxicity in rats. |
| Q90712400 | Fate of systemically and locally administered adipose-derived mesenchymal stromal cells and their effect on wound healing |
| Q48087924 | Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics. |
| Q38133556 | From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? |
| Q94554789 | Functional and histological evaluation of bone marrow stem cell-derived exosomes therapy on the submandibular salivary gland of diabetic Albino rats through TGFβ/ Smad3 signaling pathway |
| Q50961286 | G-CSF contributes at the healing of tunica media of arteriotomy-injured rat carotids by promoting differentiation of vascular smooth muscle cells |
| Q89776672 | GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels |
| Q51399595 | Gadolinium-Decorated Silica Microspheres as Redox-Responsive MRI Probes for Applications in Cell Therapy Follow-Up. |
| Q91587737 | Gadolinium-Labelled Cell Scaffolds to Follow-up Cell Transplantation by Magnetic Resonance Imaging |
| Q36260708 | Galectin-9 is Involved in Immunosuppression Mediated by Human Bone Marrow-derived Clonal Mesenchymal Stem Cells |
| Q52993941 | Generation of suppressive blood cells for control of allograft rejection. |
| Q41657642 | Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells |
| Q55331971 | Graphene-Based Nanomaterials for Tissue Engineering in the Dental Field. |
| Q39803218 | Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs |
| Q36760909 | H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells |
| Q35804026 | Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease |
| Q58908910 | Hematopoietic stem cell transplantation for systemic lupus erythematosus |
| Q37541843 | Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy. |
| Q35653315 | Hepatogenic differentiation of mesenchymal stem cells induced by insulin like growth factor-I. |
| Q33623137 | Heterogeneous nuclear ribonucleoprotein A1 interacts with microRNA-34a to promote chondrogenic differentiation of mesenchymal stem cells |
| Q61806125 | Heterologous Wharton's Jelly Derived Mesenchymal Stem Cells Application on a Large Chronic Skin Wound in a 6-Month-Old Filly |
| Q42347169 | High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling |
| Q37714126 | Homemade-device-induced negative pressure promotes wound healing more efficiently than VSD-induced positive pressure by regulating inflammation, proliferation and remodeling |
| Q44919964 | Homing properties of mesenchymal stromal cells. |
| Q38603057 | Homogeneity evaluation of mesenchymal stem cells based on electrotaxis analysis. |
| Q41820224 | Human Bone Marrow-derived Mesenchymal Stem Cell: A Source for Cell-Based Therapy |
| Q54650117 | Human marrow-isolated adult multilineage-inducible (MIAMI) cells protect against peripheral vascular ischemia in a mouse model |
| Q44297451 | Human mesenchymal stem cells from the umbilical cord matrix: successful isolation and ex vivo expansion using serum-/xeno-free culture media. |
| Q36861740 | Human mesenchymal stromal cells: identifying assays to predict potency for therapeutic selection |
| Q41889581 | Human stem cells and articular cartilage regeneration |
| Q50475357 | Human umbilical cord blood-derived mesenchymal stromal cells display a novel interaction between P-selectin and galectin-1. |
| Q64892013 | Hydrogel Biomaterials for Stem Cell Microencapsulation. |
| Q49905713 | IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate. |
| Q37299784 | IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro. |
| Q38730553 | In vitro exploration of a myeloid-derived suppressor cell line as vehicle for cancer gene therapy. |
| Q39908369 | In vivo IL13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell implants. |
| Q53367084 | Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR. |
| Q42334005 | Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment |
| Q35976735 | Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity |
| Q48539167 | Inhibition of mircoRNA-34a Enhances Survival of Human Bone Marrow Mesenchymal Stromal/Stem Cells Under Oxidative Stress |
| Q35590717 | Injectable hydrogel delivery plus preconditioning of mesenchymal stem cells: exploitation of SDF-1/CXCR4 axis toward enhancing the efficacy of stem cells' homing. |
| Q58227756 | Insulin-like growth factor 1 (IGF-I) improves hepatic differentiation of human bone marrow-derived mesenchymal stem cells |
| Q38186634 | Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. |
| Q37587747 | Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia |
| Q24595801 | Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation |
| Q37472276 | Intravenous hMSCs Ameliorate Acute Pancreatitis in Mice via Secretion of Tumor Necrosis Factor-α Stimulated Gene/Protein 6 |
| Q37531990 | Involvement of blood mononuclear cells in the infertility, age-associated diseases and cancer treatment. |
| Q50226560 | Isolation, culture, and induced multiple differentiation of Mongolian sheep bone marrow-derived mesenchymal stem cells |
| Q36055845 | Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy |
| Q50472985 | Kidney regeneration by non-platelet RNA-containing particle-derived cells |
| Q48847725 | Knockdown of MicroRNA Let-7a Improves the Functionality of Bone Marrow-Derived Mesenchymal Stem Cells in Immunotherapy |
| Q37547116 | LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells |
| Q40443985 | Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mesenchymal stromal cells in vitro via TLR4 activation |
| Q39633236 | Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration |
| Q35590681 | Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice |
| Q47134175 | Long-term drug modification to the surface of mesenchymal stem cells by the avidin-biotin complex method |
| Q42562920 | Low-density subculture: a technical note on the importance of avoiding cell-to-cell contact during mesenchymal stromal cell expansion |
| Q47103685 | MALP-2, an agonist of TLR6, promotes the immune status without affecting the differentiation capacity of umbilical cord mesenchymal stem cells |
| Q37781509 | MSCs: Biological characteristics, clinical applications and their outstanding concerns |
| Q39356606 | MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation |
| Q90392236 | MSX2 Initiates and Accelerates Mesenchymal Stem/Stromal Cell Specification of hPSCs by Regulating TWIST1 and PRAME |
| Q39171316 | Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells. |
| Q92830126 | Manufacturing of primed mesenchymal stromal cells for therapy |
| Q55546728 | Mathematical Modeling Reveals the Role of Hypoxia in the Promotion of Human Mesenchymal Stem Cell Long-Term Expansion. |
| Q42548312 | Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells. |
| Q38651379 | Mechanoresponsive stem cells to target cancer metastases through biophysical cues. |
| Q39921367 | Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow. |
| Q26860887 | Mesenchymal Stem Cell Therapy for Cutaneous Wounds |
| Q93147053 | Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate |
| Q90259526 | Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application |
| Q47136831 | Mesenchymal Stem Cells for Cartilage Regeneration of TMJ Osteoarthritis. |
| Q38246799 | Mesenchymal Stem Cells for Treating Articular Cartilage Defects and Osteoarthritis |
| Q26748517 | Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy |
| Q38782963 | Mesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus |
| Q34971854 | Mesenchymal chondroprogenitor cell origin and therapeutic potential |
| Q35558505 | Mesenchymal stem cell effects on T-cell effector pathways. |
| Q38087991 | Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation |
| Q51002334 | Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. |
| Q35774310 | Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears |
| Q54188853 | Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation. |
| Q38738066 | Mesenchymal stem cell-based gene therapy for erectile dysfunction |
| Q36352514 | Mesenchymal stem cells are injured by complement after their contact with serum |
| Q26853374 | Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment |
| Q39178437 | Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis |
| Q39253499 | Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols |
| Q38210869 | Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry |
| Q30525829 | Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms |
| Q34259085 | Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy |
| Q27003371 | Mesenchymal stem cells: immune evasive, not immune privileged |
| Q34422955 | Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. |
| Q37863460 | Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? |
| Q33958064 | Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses |
| Q37976114 | Mesenchymal stromal cells for tissue-engineered tissue and organ replacements |
| Q34541781 | Method for obtaining committed adult mesenchymal precursors from skin and lung tissue |
| Q37054490 | MicroRNAs Involved in Asthma After Mesenchymal Stem Cells Treatment |
| Q30503541 | Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions. |
| Q37617220 | Molecular Characterization of Neurally Differentiated Human Bone Marrow-derived Clonal Mesenchymal Stem Cells |
| Q47548793 | Monitoring wound healing of burn in rat model using human Wharton's jelly mesenchymal stem cells containing cGFP integrated by lentiviral vectors. |
| Q89477305 | Multi-lineage differentiation and clinical application of stem cells from exfoliated deciduous teeth |
| Q55513396 | Multimodal cell tracking from systemic administration to tumour growth by combining gold nanorods and reporter genes. |
| Q30530998 | Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing. |
| Q55155227 | Mutual Destruction of Deep Lung Tumor Tissues by Nanodrug-Conjugated Stealth Mesenchymal Stem Cells. |
| Q47707153 | Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy. |
| Q64263298 | Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge |
| Q90575138 | Nuclear shape, protrusive behaviour and in vivo retention of human bone marrow mesenchymal stromal cells is controlled by Lamin-A/C expression |
| Q54266391 | Optimal Xeno-free Culture Condition for Clinical Grade Stem Cells from Human Exfoliated Deciduous Teeth. |
| Q34150013 | Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration |
| Q89853511 | Percutaneous Fat Transfer to Treat Knee Osteoarthritis Symptoms: Preliminary Results |
| Q37695489 | Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. |
| Q38870603 | Periodontal Wound Healing by Transplantation of Jaw Bone Marrow-Derived Mesenchymal Stem Cells in Chitosan/Anorganic Bovine Bone Carrier Into One-Wall Infrabony Defects in Beagles |
| Q41959124 | Periodontal regeneration using periodontal ligament stem cell-transferred amnion |
| Q30543276 | Pre-stem cell formation by non-platelet RNA-containing particle fusion |
| Q36125132 | Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome |
| Q42277124 | Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer |
| Q97529881 | Raman image-activated cell sorting |
| Q37167384 | Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: a case series |
| Q37895216 | Regenerative medicine and connective tissues: cartilage versus tendon. |
| Q35892642 | Remote Ischemic Postconditioning Ameliorates the Mesenchymal Stem Cells Engraftment in Reperfused Myocardium |
| Q30399021 | Remote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrier |
| Q38085053 | Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy |
| Q42366725 | Role of aryl hydrocarbon receptor in mesenchymal stromal cell activation: A minireview |
| Q38846451 | Role of stem cell factor in the placental niche |
| Q38917884 | Scaffold-free, stem cell-based cartilage repair |
| Q35906866 | Sensing the cardiac environment: exploiting cues for regeneration |
| Q52776165 | Significant curative functions of the mesenchymal stem cells on methotrexate-induced kidney and liver injuries in rats. |
| Q39494504 | Simple evaluation method for osteoinductive capacity of cells or scaffolds using ceramic cubes |
| Q38540260 | Stem Cells for Temporomandibular Joint Repair and Regeneration |
| Q34111083 | Stem cell approaches for the treatment of type 1 diabetes mellitus |
| Q34290347 | Stem cell educator therapy and induction of immune balance |
| Q38042584 | Stem cell therapy: from bench to bedside |
| Q35568777 | Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells |
| Q37907900 | Stem cells in the treatment of cardiovascular disease--an overview |
| Q30577136 | Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal. |
| Q34934863 | Synthetic surface for expansion of human mesenchymal stem cells in xeno-free, chemically defined culture conditions |
| Q61454884 | Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer |
| Q37483158 | Systematic analysis of in vitro cell rolling using a multi-well plate microfluidic system |
| Q36085591 | Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation |
| Q57466990 | The Potential of Intrinsically Magnetic Mesenchymal Stem Cells for Tissue Engineering |
| Q56837269 | The Safety of Non-Expanded Multipotential Stromal Cell Therapies |
| Q35186756 | The TLR7 agonist Imiquimod promote the immunogenicity of mesenchymal stem cells |
| Q53569718 | The expression of neurogenic markers after neuronal induction of chorion-derived mesenchymal stromal cells. |
| Q33577019 | The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis |
| Q41430366 | Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression |
| Q45947247 | Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis. |
| Q87412482 | Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats |
| Q35609423 | Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice. |
| Q36633005 | Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. |
| Q26991746 | Therapeutic potential of mesenchymal stem cells for oral and systemic diseases |
| Q38191582 | Therapy with stem cells in inflammatory bowel disease |
| Q55221537 | Three-Dimensional Graphene-RGD Peptide Nanoisland Composites That Enhance the Osteogenesis of Human Adipose-Derived Mesenchymal Stem Cells. |
| Q64012586 | Tissue repair and regeneration with endogenous stem cells |
| Q37093530 | To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells |
| Q36102133 | Tolerogenic therapies in transplantation. |
| Q36790753 | Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells |
| Q37997539 | Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. |
| Q37627675 | Ultrasound-Mediated Mesenchymal Stem Cells Transfection as a Targeted Cancer Therapy Platform |
| Q26798214 | Umbilical Cord Tissue-Derived Cells as Therapeutic Agents |
| Q38647621 | Unmet needs: Research helps regulators do their jobs |
| Q42579200 | Unsaturated fatty acids induce mesenchymal stem cells to increase secretion of angiogenic mediators |
| Q33588145 | Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo |
| Q30548207 | mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. |
Search more.